ABSTRACT: This work outlines the unequivocal identification of the "ecstasy" analog, 2-chloro-4,5-methylenedioxymethylamphetamine, using combined gas chromatography/mass spectroscopy (GC/MS) and proton magnetic resonance spectroscopy ( 1 H-NMR). This compound was identified along with 3,4-methylenedioxymethylamphetamine (MDMA) in an illicit tablet seizure, which included 26 off-white tablets.
This substance was isolated by thin layer chromatography (TLC) and subsequently identified as 2-chloro-4,5-methylenedioxymethlamphetamine using data obtained from proton magnetic resonance spectroscopy ( 1 H-NMR), and GC/MS using electron impact and positive ion chemical ionization methods.
Methods

Thin Layer Chromatography
TLC plates: Silica stationary phase; layer thickness, 0.25 mm; plate size, 20 cm ϫ 20 cm. Eluent: toluene diethylamine (95: 5) .
A sample of a tablet (approximately 50 mg) was placed into a glass vial containing methanol (approximately 0.5 mL), from which 16 extracts were spotted at regular intervals, using a capillary tube, 1 cm from the base of the TLC plate. This procedure was repeated six times on separate TLC plates. A standard MDMA solution, as a reference, and a methanol blank were also spotted once on each plate. The samples were eluted in toluene and diethylamine (95:5 v/v). The bands were visualized under an ultraviolet (UV) light.
Gas Chromatography/Mass Spectroscopy
Positive Ion Chemical Ionization-Analyses were performed using a Hewlett Packard 5890 Series II gas chromatograph with a Hewlett Packard 7673 GC-STC autosampler, coupled to a Hewlett Packard 5989A quadrapole mass spectrometer. The compounds of interest were detected using the following GC/MS conditions. One microliter of sample was injected into the instrument operating in the splitless mode; the carrier gas was helium 13.5 psi (93 kPa); the reagent gas, methane (purity 99.95%).
Initial temperature, 100°C for 1 min., 1st ramp rate, 10°C/min to 150°C, 2nd ramp rate, 20°C/min to 300°C held for 2 min., injection temperature 250°C; transfer line temperature, 250°C; source temperature, 200°C; quadrapole temperature, 100°C; source manifold pressure, 2.7 ϫ 10 Ϫ4 torr; analyzer manifold pressure, 4.3 ϫ 10 Ϫ6 torr; foreline pressure, 1.4 ϫ 10 Ϫ1 torr; methane pressure, 1.8 torr.
GC column, HP5; length, 30 m ϫ 0.25 mm, film thickness 0.25 m.
The mass spectrometric scanning control parameters were as follows: start mass 40 amu; end mass 500 amu; scan time 0.9 s; interscan time 0.10 s.
Electron Ionization-Analyses were performed using a Hewlett Packard 5890 Series II gas chromatograph with a Hewlett Packard 7673 GC-STC autosampler, coupled to a Hewlett Packard 5972 quadrapole mass spectrometer.
The compounds of interest were detected using the GC conditions and the MS setup applicable to EI as detailed above.
H-NMR Spectroscopy
The NMR spectra were measured in deuteriochloroform solutions using a Bruker DPX 360MHz spectrometer operating at 360.13 MHz for protons. Spectra were recorded at 303 K, and were referenced to internal TMS at 0 ppm.
Derivatization
A sample of the tablet (10 mg) was placed into a screwtop glass vial (2 mL) to which was added an aqueous solution of 12.5 mM diphenylpyraline (DPP) as an internal standard (250 L). An aqueous solution of 1 M Tris buffer solution (250 L) followed by toluene (500 L) was added to the vial which was then vortexed for approximately 20 s. An aliquot of the supernatant (25 L) was removed and diluted 1:10 in toluene. Heptafluorobutyric anhydride (5 L) together with a 10% solution of sodium hydrogen carbonate (250 L) was added to the dilution and vortexed for approximately 20 s.
The supernatant layer was removed and dried over anhydrous sodium sulfate prior to GC/MS analysis.
A sample of the unknown component, isolated by TLC, was also derivatized as above. 
Results and Discussion
TLC
Each TLC plate was viewed under UV light, which visualized two clearly defined and resolved bands. The calculated relative front (R ƒ ) value for the MDMA standard (R ƒ ϭ 30.3) corresponded to one of the separated bands of the extracted sample. The R ƒ value of the remaining band was calculated as R ƒ ϭ 34.9. This band (R ƒ ϭ 34.9) was scraped from each plate, divided in two and placed into separate vials. One portion was extracted with toluene (1 mL) and the other with deuteriochloroform (1 mL) for subsequent derivatization prior to GC/MS and 1 H-NMR studies, respectively, as previously described.
GC/MS
Electron Ionization (EI/MS)-The heptafluorobutyryl derivatives of MDMA (retention time ϭ 9.29 min) and the unknown compound, (retention time ϭ 10.02 min) were clearly defined and separated according to their retention times (Fig. 1) . The internal standard (DPP) was also noted (retention time ϭ 11.49). The EI/MS spectra of both MDMA and the unknown compound (Figs.  2a and 2b) The HFBA derivative of the unknown band (R ƒ ϭ 34.9) recovered from the TLC experiments produced a mass spectrum identical to the proposed Cl-MDMA analogue (results not shown). ϩ exhibits a characteristic A ϩ 2 isotopic cluster indicative of a mono-chloro substituted compound (Fig. 3) . 
Positive Ion Chemical Ionization (PCI/MS)-The
FIG. 2b-EI/MS of CI-MDMA.
from the methyl protons of the {ϪNH 2 -Me} group, the triplet structure due to coupling of these H's with the NH 2 protons. Signals C and E are due to the diastereotopic H's of C(1). Each is a doublet of doublets of relative integral 1, each showing coupling to its diastereotopic partner (13.2 Hz) and to the adjacent CH, H(2), (10.3 Hz for C and 4.2 Hz for E). Signal D is a broad complex multiplet of relative integral 1, and is due to H(2). The complexity of the signal is due to it being coupled to the protons on carbon atoms 1 and 3, and to the NH 2 protons.
Signal F, of relative integral 2, is due to the methylenedioxy protons.
Signals G, H, and J are due to the aromatic protons H(2Ј), H(5Ј), and H(6Ј). Signal J is a doublet J ϭ 7.8 Hz, and hence arises from H-5Ј, coupling with H-6Ј. Signal G is a doublet of doublets J ϭ 7.8, 1.7 Hz, from H-6Ј coupling to H-5Ј and H-2Ј, respectively. With signal H as a narrow doublet, J ϭ 1.7 Hz, due to H-2Ј.
Signal K, of relative integral 2, is hence assigned as the {ϪNH 2 -Me} protons.
These data are entirely consistent with the known structure (Fig.  5) .
Chlorinated MDMA Analog-The 1 H-NMR spectrum of the chlorinated analogue (in its base form), isolated by TLC, was also acquired, again in deuteriochloroform solution (Fig. 6) . The spectrum was made up of seven distinct groups of signals, A-G (see Table 1 for chemical shift values). The remaining signals arise from impurities either in the solvent, or carried over from the iso- lation procedure. Signals F and G (each relative integral 1) are due to the aromatic protons 3Ј and 6Ј. These two aromatic H's with their singlet appearance confirm the para arrangement of the protons on the aromatic ring, i.e., in the 3Ј and 6Ј sites.
Signal E (relative integral 2) arises from the methylenedioxy protons. Signal A, a doublet (relative integral 3), derives from the H-3 (methyl) protons and B (also relative integral 3) arises from the methyl protons of the {ϪNH-Me} group. In this case no coupling is observed to this signal. Signal C (integral 1), a doublet of doublets, J ϭ 15.5, 8.9 Hz, is due to one of the diastereotopic H-1 pair, with the peak labeled D (integral 2) resulting from the overlapping of the other H-1 and the H-2 signal. The trigonal N-H is not observed.
Once again, this spectrum is entirely consistent with the proposed structure (Fig. 7) .
In accordance with IUPAC rules, the numbering scheme differs to that of the parent around the aromatic ring, thus substitution is thought to have taken place at the 2Ј position, as indicated. (Insufficient sample was available to convert the base form of the Cl-MDMA to its hydrochloride salt for further analysis.) Tablet Sample-The 1 H-NMR spectrum of a deuteriochloroform extract from a tablet sample was acquired, with the result as shown in Fig. 8 .
The spectrum consists of 18 signals, labeled A-T. Some of these signals are assignable to MDMA on the basis of either signal intensity or analogy with the spectrum of pure MDMA, the clearest of these being A,C,E,K,M,N, and P. Although there is some overlap of some of the remaining signals, others can be as- signed directly to the Cl-MDMA analog. For example, signals Q and R, both singlets of relative integral 1, are ascribable to the para protons of Cl-MDMA. The aliphatic region of this spectrum is very congested, particularly in the area between signals C and J. Nonetheless, some distinct signals due to Cl-MDMA can be seen. Signal D is analogous to signal C, and arises from the methyl protons of the {ϪNH 2 ϪMe} group, the triplet structure due to coupling of these H's with the NH 2 protons S/T. Hence, confirming both analogs to be present in the salt form. Signal F,
like signal E, is a doublet of doublets, J ϭ 14.1, 11.1 Hz, and arises from one of the diastereotopic H-1 protons. Overall therefore, the main difference between the 1 H-NMR spectra of the two analogs (as the HCl salts) lies in the appearance of the aromatic region and, as described above, it is this region of the spectrum that is critical in determining the position of the Cl atom on the aromatic ring. 
Conclusions
The analysis of "designer" drugs such as ecstasy by chromatographic methods is complicated by the unavailability of reference materials. However, by using a systematic approach involving techniques such as GC/MS and 1 H-NMR, it is relatively simple to achieve an unambiguous identification of these drug types. In this instance we have identified a chlorinated analog of MDMA by mass spectrometry, and have confirmed its isomeric form as 2-chloro-4,5-methylenedioxymethylamphetamine by 1 H-NMR.
